Thomson Reuters Corporation’s (TSE:TRI) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?

Dec 3, 2025
thomson-reuters-corporation’s-(tse:tri)-stock-has-shown-weakness-lately-but-financial-prospects-look-decent:-is-the-market-wrong?

With its stock down 25% over the past three months, it is easy to disregard Thomson Reuters (TSE:TRI). However, the company’s fundamentals look pretty decent, and long-term financials are usually aligned with future market price movements. Specifically, we decided to study Thomson Reuters’ ROE in this article.

Return on equity or ROE is a key measure used to assess how efficiently a company’s management is utilizing the company’s capital. In simpler terms, it measures the profitability of a company in relation to shareholder’s equity.

AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part – they are all under $10bn in marketcap – there is still time to get in early.

ROE can be calculated by using the formula:

Return on Equity = Net Profit (from continuing operations) ÷ Shareholders’ Equity

So, based on the above formula, the ROE for Thomson Reuters is:

15% = US$1.8b ÷ US$12b (Based on the trailing twelve months to September 2025).

The ‘return’ is the amount earned after tax over the last twelve months. Another way to think of that is that for every CA$1 worth of equity, the company was able to earn CA$0.15 in profit.

See our latest analysis for Thomson Reuters

We have already established that ROE serves as an efficient profit-generating gauge for a company’s future earnings. We now need to evaluate how much profit the company reinvests or “retains” for future growth which then gives us an idea about the growth potential of the company. Assuming all else is equal, companies that have both a higher return on equity and higher profit retention are usually the ones that have a higher growth rate when compared to companies that don’t have the same features.

To begin with, Thomson Reuters seems to have a respectable ROE. Be that as it may, the company’s ROE is still quite lower than the industry average of 21%. Needless to say, the 18% net income shrink rate seen by Thomson Reutersover the past five years is a huge dampener. Not to forget, the company does have a high ROE to begin with, just that it is lower than the industry average. Therefore, the shrinking earnings could be the result of other factors. These include low earnings retention or poor allocation of capital.

That being said, we compared Thomson Reuters’ performance with the industry and were concerned when we found that while the company has shrunk its earnings, the industry has grown its earnings at a rate of 12% in the same 5-year period.

Leave a comment